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Introduction: Obesity rates continue to rise and more total hip arthroplasty procedures are being performed in
progressively younger, obese patients. Hence, maintenance of long term physical function will become very
important for quality of life, functional independence and hip prosthesis survival. Presently, there are no reviews of
the long term efficacy of total hip arthroplasty on physical function. This review: 1) synopsized available data
regarding obesity effects on long term functional outcomes after total hip arthroplasty, and 2) suggested future
directions for research.
Methods: A literature search was conducted from 1965 to January of 2011 for studies that evaluated long term
functional outcomes at one year or longer after THA in obese (body mass index values ≥30 kg/m2) and non-obese
patients (body mass index <30 kg/m2).
Results: Five retrospective studies and 18 prospective studies were identified as those that assessed physical
function before surgery out to≥ one year after total hip arthroplasty. Study sample sizes ranged from 108–18,968
and followed patients from one to twenty years. Total hip arthroplasty confers significant pain reduction and
improvement in quality of life irrespective of body mass index. Functional improvement occurred after total hip
arthroplasty among all studies, but obese patients generally did not attain the same level of physical function by
the follow-up time point.
Discussion: Uncontrolled obesity after total hip arthroplasty is related to worsening of comorbidities and excessive
health care costs over the long term. Aggressive and sustainable rehabilitation strategies that include physical
exercise, psychosocial components and behavior modification may be highly useful in maximizing and maintaining
weight loss after total hip arthroplasty.
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The obese segment of the population with osteoarthritis is
burgeoning, and the demand for total hip arthroplasty
(THA) surgeries to treat obese persons is rising rapidly. Pri-
mary THA procedures will likely become necessary for a
greater prevalence of the U.S. population who is developing
debilitating OA earlier in life, and revision THAs will be-
come more frequent as these young adults age and the life
of the joint component ends. Evidence indicates that the
relative risk ratio for undergoing elective hip replacement* Correspondence: vincehk@ortho.ufl.edu
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reproduction in any medium, provided the orranges from 1.92 in overweight individuals to 8.56 in se-
verely obese individuals [1]. While extensive evidence has
focused on surgical outcomes, mortality medical complica-
tions after hip replacement [2], the relationship between
functional outcomes and obesity after THA over the long
term is not well understood, particularly in the obese pa-
tient. This is a significant scientific deficit as restoration of
physical function is one of the primary goals of THA [3,4].
As obesity rates continue rising and more THAs are
being performed in progressively younger, obese patients,
long term functional goals will become important. Func-
tional goals may include maintaining independence with
load bearing activities of daily living, independent mobility
and body transfers over the long term. Many obese patientsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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demand or weight bearing activity) for weight loss. In
addition, progressively more obese patients with THA will
be living longer with a joint implant and may be at risk for
failure and poorer quality of life over the long duration
compared with non-obese patients. For example, 35% of
patients with THA experience severe activity limitation by
year five; obesity significantly predicted complete depend-
ence on walking aids and is associated with depression at
follow-up [5]. The physical component of quality of life is
also lower in obese patients years after the procedure [6-8].
Hence, a clear understanding the effect of obesity on func-
tional outcomes after THA will be critical in establishing
expectations for the patients and care team and develop-
ment of strategies to optimize physical function and inde-
pendent mobility for as long as possible. Therefore, the
purposes of this review are to: 1) provide a current synopsis
of the available data regarding obesity effects on long term
functional outcomes after THA, and 2) to suggest future
directions for research.
Search strategy
We conducted a literature search from 1965 to January
of 2011 in Medline, Cochrane Controlled Trials Register,
CINAHL, Scopus and Web of Science. The search strat-
egy identified studies in English that examined the rela-
tionships between obesity or BMI, physical function after
total hip replacement. A functional measurement of mo-
bility, ambulation or transfers or a comprehensive self-
report tool that assesses physical function had to have
been reported a minimum of six months of follow-up
after surgery. Estimates of obesity had to have been
reported including body mass index (BMI), body fat per-
centage or fat mass. Medical subject headings (MeSH)/
keywords with all subheadings and as free text included
obesity, obese, mobility, functional limitation, physical
function, body fat, adiposity, waist circumference, total
hip replacement and hip arthroplasty. Studies that admi-
nistered surveys that reflected the perceived physical
functional ability were also included; these tools included
the Oxford Hip score (OHS), Harris Hip score (HHS),
Western Ontario McMaster Osteoarthritis Index
(WOMAC) score or other specially constructed surveys
that included function-based questions, such as the Uni-
versity of California Los Angeles (UCLA) hip scoring
system. Studies that used functional tests (walking tests,
chair rise or timed up and go or body transfers or other
self care tasks) were also included. A total of 552 papers
were initially generated from this search. Studies that
had a follow-up of less than six months, did not report
any form of functional measure at follow-up or did not
include an assessment of obesity were not included. The
lists of references of retrieved publications were manu-
ally checked to add any citations missed by the electronicsearches. Obesity was defined as an excessive body
weight >100 kg, a BMI ≥30 kg/m2 [9], or a large waist
circumference (>88 cm women, >102 cm men) [10].
Characteristics of included studies
A total of 23 articles were reviewed. Twenty articles
included self-report assessments of the WOMAC, HHS
or OHS or other survey based tools of physical function.
Eight studies included objective physical function assess-
ments. Studies were conducted in the United States
[7,11-13], Europe (Netherlands [14], Scotland [15], the
United Kingdom [6,16-19], Switzerland [3], Denmark
[20]), Canada [2,21] and Australia [22-25]. Study sample
sizes ranged from 140 [15] to 18,968 [3] and were com-
prised of 17-77% women, depending on the study. We
identified three multicenter studies (two from Britain,
one from Switzerland, and one with 7 to 20 sites)
[3,16,18] and two studies based on joint surgery regis-
tries (American-based registry study) [13] and a Canad-
ian based registry [26].
Several studies demonstrated variability in the follow-up
time points for assessment, which limits generalizability of
the findings. For example, two retrospective studies cap-
tured follow up data from 0.1-15.6 years [14] and from
10–18.9 years [11]. Other retrospective studies captured
follow-up times out to one year [2] or at different points of
time during the years following the surgery [7,11,24]. A
few prospective studies contained follow-up data from dif-
ferent time points during years following the procedure
[23,27].
Hip surgical components and approaches
Surgical technique, component type and use of cement
varied among and within the identified studies. Several
surgical techniques were used across the studies, includ-
ing anterolateral [6,14,16,19], posterior [7,16,23], lateral
[28] and posterolateral [11,20] approaches. There was
also variation in the type of component used, and ce-
ment use for fixation of the component. Cement proce-
dures were described in six studies [6,7,14,15,29,30], and
two studies described a mixed procedure of one cemen-
ted component and one non-cement component [28,31].
Numerous studies did not report or clearly describe the
components or the surgical procedure [2,3,13,15,17-
19,22,24,26,29,32]. Only a few of the studies controlled
the number of surgeons performing the arthroplasties,
thereby providing some control over the variation in the
operating room procedures [17,23,24]. Therefore, the
specific surgical details were widely varied among the
study pool.
Retrospective evidence
We identified five retrospective studies, and the sum-
maries of these studies are found in Table 1. Three
Table 1 Retrospective studies of functional outcomes in obese and non-obese patients with total hip arthroplasty
(THA)
Study N Follow-up Sample Surgical Type & Components Results
Braeken
et al [2] (1997)
193 to 1 year; Retrospective
Mean age 63.5 years
61% were women BMI was
found for each patient
Surgical components not
described; surgical type not
described: data obtained from
medical charts and mailings
While high BMI was related
to high postoperative pain
levels, BMI itself was not a






et al [14] (2008)
411 Mean out to 20 years;
Retrospective
69% were women; BMI groups
were <25, ≥ 25 and >30 kg/m2
Mean ages were 64–66 years
among groups
Anterolateral approach;
Weber rotation THA System
(Allopro) with cement;
HHS scores were progressively
lower for higher BMI brackets
at maximum follow-up time
(91.6, 86.8 and 83.7 points;
p=0.02); revision rates were






17% were women BMI groups
were< or≥ 30 kg/m2
Mean age 49 years
Posterior approach; 30-37%
of metaphyseal stem femoral
components were cemented;
Conserve Plus hip resurfacing
prostheses were used
By 6.2 years of follow-up, UCLA
scores for function and activity
werelower in the obese patients
than non-obese patients by ~8%;
SF-12 physical component scores
were also lower in the obese
group (49.3 vs 51.4 points;
p=0.013); 5 year survivorship was
90.6% and 98.6% in patients with






51% were women; BMI groups
were <30 or ≥30 kg/m2 Mean
ages 54–57 years
Uncemented T-tap acetabular
components (Biomet Inc.) and
Taperloc femoral points in obese
patients and from 53 to components
were used by one surgeon; all
were posterolateral approaches
By follow-up HHS " from 52 to
89 89 points in non-obese
patients, with no difference
between groups; no differences




2,026 6.3 year mean
follow-up; Retrospective
53% were female; BMI groups
were <30 or ≥30 kg/m2
Cementless procedures used;
components and approached were
not described
HHS scores were lower for the
obese compared to the
non-obese patients at
follow-up (89.9 vs 93.2 points;
p< 0.001); HHS scores for
function, activities, hip range
of motion were lower in the
obese group (all p< 0.05);
survival rates were for the
implants were similar at year
11 (95-96%)
THA = total hip arthroplasty; BMI = body mass index; EUROHIP = European Collaborative Database of Cost and Practice Patterns of Total Hip Replacement.
OR = odds ratio; RR = relative risk; HHS = Harris Hip Score; UCLA = University of California and Los Angeles (UCLA) activity scale; Medical Outcomes SF-12 = Short
Form 12; WOMAC = Western Ontario and McMaster Osteoarthritis Index; VAS = visual analogue scale.
NS = not specified.
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over varied follow-up time points out to 20 years. A
BMI value of >30 kg/m2 was related with a 4-9% lower
HHS scores at follow-up than BMI values less than
30 kg/m2 [14,24]. Despite HHS score differences, im-
plant survival duration was similar by year 11. One
study that assessed follow-up HHS scores did not find
differences in improvement levels between non-obese
and obese patients after the procedure [11]. This corre-
sponded with no differences in revision rates or medical
complications. Two other reports showed that patients
with higher BMI values had 4-9% lower HHS scores atmaximum follow-up time of 1–10 years [14,24], and sig-
nificantly less range of motion during hip flexion, ad-
duction, internal rotation and lower knee flexion values
than patients with normal BMI values. Similar to the
findings of McLaughlin and Lee [11], Yeung et al [24]
reported no differences in the probability of 11 year in
implant survival based on BMI.
One study examined whether the functional and qual-
ity of life outcomes of hip resurfacing varied among non-
obese and obese patients using data obtained from an in-
stitutional registry [7]. Data were obtained from clinical
visits at four months, one year and annually after
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In obese patients, post-operative HHS score were 3.2
points lower, UCLA sub-scores for “function” and “activ-
ity” were 4-7% lower than those of the non-obese
patients. UCLA sub-scores of “walking” were not differ-
ent between groups. Interestingly, survival of the hip im-
plant was higher in the obese patients compared to the
non-obese patients by year 5 (98.6% vs 90.6%).
Prospective evidence
Table 2 summarizes the prospective studies that we iden-
tified. Six studies used HHS as primary endpoints
[6,8,15,17,19,28], one study used OHS [16], one used the
UCLA activity score [31], and six studies employed the
WOMAC survey scores [8,18,26,28,34,35] as a main out-
come. Six studies used actual functional measures and
patient reported functional abilities [3,12,20,23,34,35].
Harris hip score
HHS scores and functional sub-scores were captured at
a variety of time points ranging from one to five years.
In one study, sub-scores of HHS were reported in non-
obese and obese patients with THA by three years post-
surgery [15]. Sub-scores of walking distance, climbing
stairs, putting on shoes and socks, sitting and hip range
of motion were 4-25% lower in the obese group at fol-
low-up. Despite mean improvements in HHS and mobil-
ity, the cohort tended to gain weight by year three.
Another study tracked functional and clinical outcomes
in a group of morbidly obese patients with THA out to
year five; HHS scores improved significantly in all
patients by month six [6]. While the HHS scores were
higher in non-obese patients by year five, the absolute
improvement in scores were not different based on obes-
ity status (52.0 vs 48.1 point change). Also, the morbidly
obese patients had more peri-operative complications
(12 vs 3 complications) and the five year survival was
90.9% and 100% in the obese and non-obese patients.
Both sex and revision status may be important factors
influencing HHS outcomes. For example, HHS scores
were evaluated among patients with a primary or revi-
sion THA in a Swiss cohort [28]. Patients with revisions
had a relative risk of 1.67 for being obese, and BMI was
found to be a stronger inverse predictor of HHS after re-
vision procedures than primary procedures by year five.
In a related study by the same author [8], HHS scores
were collected in Swiss patients five years after THA
procedures and found that 81% and 70% of non-obese
and obese patients had good to excellent outcomes,
defined as a HHS score ≥80 points. These poorer out-
comes were magnified in women than men. For example,
HHS scores in non-obese and obese women were 87.8
and 79.6 points respectively, and were 90.5 and 87.4
points in non-obese and obese men.Among predictive and correlational studies, Moran et al
[19] examined whether BMI predicted HHS scores at fol-
low-up times of six and 18 months post-THA. While no
BMI-specific HHS data were presented, the authors
reported a small but significant multiple regression coeffi-
cient for BMI on the model for the follow-ups HHS. This
translated to a reduction in HHS by 0.25-0.35 points per
one point increase in BMI value. Another correlational
study that we included did not report actual HHS scores,
but superimposed HHS scores onto the Rosser Disability
Index matrix to generate a “quality of life” score as a
method of estimating functional disability [17]. The find-
ings revealed that the median quality of life scores were
not different among patients with low and high BMI values
at one and three years of follow-up [17]. The authors con-
cluded that progressively higher BMI values up to 40 kg/
m2 were not related with these disability estimates.
WOMAC scores
One study examined the predictive value of one to four fac-
tors relating to the metabolic syndrome on WOMAC
scores before and at one year after THA [26]. These factors
included large waist circumference (>102 cm men, >88 cm
women), elevated triglycerides and low high density lipopro-
tein cholesterol, high blood pressure and elevated fasting
blood glucose. BMI was calculated for each patient. Regres-
sion analyses were performed to determine the effect of the
number of metabolic syndrome factors on WOMAC scores
by year one. The regression beta coefficient of having 4
metabolic factors on prediction of WOMAC scores was
16.1 in this obese patient group compared with the beta co-
efficient of 0.6 in non-obese patients with one factor. The
coefficient for obesity alone was 2.4 (p=0.03).
A study that analyzed data from twelve European
countries showed that one year WOMAC scores are
related to BMI [18]. Median baseline WOMAC scores
were higher in morbidly obese and obese patients com-
pared with non-obese patients (68.1 and 61.5 vs 57.6
points) but the median change in WOMAC scores was
highest in the morbidly obese group by year one (56.1 vs
33.3 and 37.5 points; p = 0.012). In this cohort, the multi-
variate odds ratio of returning to normal functional sta-
tus was 3.1 compared to non-obese patients.
Lubbeke et al. performed two hospital-based cohorts
examining the 1) five year outcomes in obese men and
women with THA [8], and 2) the effects of comorbidities
and age after primary and revision THA [28]. In the first
study, sex differences in survey outcomes were analyzed in
a cohort of patients with THA. The crude incidence rate
was 4.7 times higher for infection, and the incidence rate
was 2.3 times higher for dislocation in obese patients com-
pared to non-obese patients. Five-year WOMAC function
sub-scores were 11% lower in obese women than men and
8% lower in non-obese women than men. Within each sex
Table 2 Prospective studies of functional outcomes in obese and non-obese patients with total hip arthroplasty (THA)
Study N Follow-up Sample Surgical Type &
Components
Results
Aderinto et al [15]
(2005)








At year 3, HHS scores " from 44 to
90 points (non-obese) and from
42.5 to 85 points (obese), with no
difference between groups; lower
scores for stairs, sitting and putting on
shoes-socks and range of motion
were lower in the obese patients
(p< 0.05).
Andrew et al [16]
(2008)




<30, 30-< 40 and
≥40 kg/m2 Mean








By year 5, OHS scores were
best in the non-obese group
and worst in the obese group
(19.6 vs 25.6 points; p = 0.005),
but no differences in the 5 year
change in OHS scores existed.
No differences in rates of revision,
dislocations or medical
complications existed.
Busato et al [3]
(2008)
18,968 15 years; Multi-
center prospective
sexes NS; BMI groups
were <25, 25- <30
and≥ 30 kg/m2
Surgical components not
described; surgical type not
described; Data were
obtained from the Total Hip
Registry (Switzerland)
High preoperative BMI was related
with a dose-effect response with
shorter unsupported walking
time less normal stair climb, and
shoe tying during the 15 year
follow-up, despitesimilar pain
relief across BMI brackets.
Chan and Villar [17]
(1996)
166 to 3 years;
Prospective cohort
59% were women BMI
groups were <25,
25–29.9, 30–39.9,
>40 kg/m2 Mean ages





HHS scores were superimposed
onto the Rosser Index Matrix
(which ranks disability status); there
were no differences in Rosser scores
for disability among the BMI groups
by year 3.
Chee et al [6]
(2010)
108 5 years; Prospective
cohort
41% were women; BMI
groups were <35 kg/m2
or >35 (1 comorbidity)
and >40 kg/m2
Anterolateral approach was
used on all patients; 25.5%
Charnley prosthesis
(dePuy, Int.), 74.5% Lubinus
SPII prosthesis (Waldmar-Link
GmbH); cemented
Five year HHS were higher in
non-obese than morbidly obese
patients (91.8 vs 85.4 points;
p< 0.0001) despite similar pre-
operative scores; SF-36 subscores
for physical functioning were lower
in morbidly obese patients at
year 5.
Dowsey et al [29]
(2010)
471 1 year; Prospective
follow-up
60% were women; BMI




not described; cement used
varied across groups
Morbidly obese patients had a
lower change in HHS function
scores than obese and non-obese
patients, respectively by year
1(11.5 vs 15.6 and 16.2 points,
respectively); HHS were lowest
in morbidly obese patients by
year 1 (70.5 vs 79.8 and 80.8
points p = 0.03).
Gandhi et al [26]
(2010)












1 year WOMAC scores (pain, function)
were highest in patients with 4
metabolic syndrome factors compared
to those with fewer factors; regression
B coefficients showed that obesity
predicted 1 year WOMAC scores
(B=2.4 1.4-4.2; 95% CI).
Jackson et al [23]
(2009)










HHS were lower in obese vs
non-obese patients at follow-up
(89.9 vs 93.2 points); HHS functional
scores were also lower in the
obese group (29.6 vs 31.0 points);
hip flexion, adduction and internal
rotation ranges were less in the
obese vs non-obese patients. HHS
pain scores were not different
between groups.
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Table 2 Prospective studies of functional outcomes in obese and non-obese patients with total hip arthroplasty (THA)
(Continued)
Judge et al [18]
(2010)
1,327 1 year EUROHIP
Study of 20 orthopedic
centers
56% were women;
BMI groups were <30,
30–39 and ≥40 kg/m2




Median WOMAC scores were highest
in the morbidly obese group pre-THR,
(68.1 vs 61.5 and 57.6 points).
but the 1 year change in WOMAC
score was highest in the morbidly
obese group (median score change
of 56.1 vs 33.3 and 37.5 points);
morbidly obese patients showed
a " OR of “returning to normal”
(functionality) than the other groups.






< or≥ 30 kg/m2
Mean ages were
68 72 years
85% of patients had mixed
components
(1 cemented,1 non)
Obesity was related with worse
outcomes after revision than primary
THA by year 5 (lower HHS scores: 76.7
vs 88.1 points; lower WOMAC function
scores 61.6 vs 70.0 points). BMI was
related to the mean difference of
HHS scores for primary and revision
THA (R coefficient=−1.0
[−0.1 to −1.95% CI]).






BMI groups were< or≥30
kg/m2 Mean age 69 years
95% were lateral THA approach,
86% used Morscher press-fit
uncemented actetabular
component and Muller
straight stem cobalt chromium
femoral component
BMI of ≥30 kg/m2 was related with a
RR of 3.7-4.0 for revisions, 9.1-12.5 for
dislocations and1.9-8.0 for infections
in obese compared to non-obese
men and women. By year 5, HHS
were 87.8 and 79.6 points in non-
obese and obese women and 90.5
vs 87.4 points in non-obese and
obese men; WOMAC function
scores were 14.7% and 8.0% lower
in obese women and men thantheir
non-obese counterparts.






or≥ 30 kg/m2 Age
range <50 to ≥80 years
Cemented acetabular cups
were used in 67% and 80%
of obese and non-obese
patients
HHS were 82.8±14.7 and 71.4±17.0
points in the non-obese and obese
patients by year 5. Surgical revisions
were performed at 92 and 125 months
in obese and non-obese groups,
respectively. The adjusted hazard ratio
for occurrence of infection, dislocation
or re-revision increased from 1.0
(BMI< 25) to 1.5 (BMI 25–29.9) to
4.5 (BMI 30–34.9) to 10.9 (BMI ≥35.0).
Lubbeke et al [31]
(2010)
503 5 or 10 years;
Prospective follow-up
58% were women; BMI
groups were <25, 25–29.9
and≥30 kg/m2
Hybrid prosthesis; Morscher
press fit uncemented cup and
cemented cobalt-chromium
stem (Zimmer); alumnia
ceramic head, and a ceramic-
polyethylene surface
At year 5, HHS # with each rogressively
higher BMI group (91.4, 88.4 and 85.1
points; p=0.019). At year 10, HHS
tended to be lower in patients with
BMI ≥30 kg/m2 compared with those
with BMI <25 and 25–29.9 kg/m2
(83.6 vs 87.3 and 87.1 points; p=0.08);
more obese patients had low UCLA
scores and more non-obese patients
had higher UCLA scores.
Moran et al [19]
(2005)
800 6–18 mo; Prospective
follow-up
61% women; BMI groups
were <25, 25–29.9,
30–39.9 ≥40 kg/m2 Mean





For every 1 point increase in BMI,
HHS scores dropped by 0.25 by
month 6 and by 0.35 by month
18 post-surgery. No BMI effect on
early failure of THA was found.
Naylor et al [22]
(2008)
198 1 year; Prospective
observational
56% were women; BMI
groups were <30





Obese patients had smaller increases
in timed mobility than non-obese
patients (0.23 m/s slower on 15 m
walk time) and the timed up and
go test (3.1 sec slower) at year 1;
WOMAC scores for function and
pain were worse in obese than
non-obese patients by year 1.
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Table 2 Prospective studies of functional outcomes in obese and non-obese patients with total hip arthroplasty (THA)
(Continued)
Singh et al [12]
(2009)
2,687 2–5 years; Prospective
cohort of revision THA
53-54% were women; BMI
brackets were <25,
25–29.9, 30–39.9 ≥40 kg/m2





At year 2, the OR for complete
dependence onwalking/gait aids
was 2.0 (vs 0.9 for BMI 25–29.9);
moderate to severe activity
limitation was predicted by
high BMI. The OR of reporting
difficulty in 3 of 7 mobility and
functional tasks " from 1.2 to 2.7
with increased BMI from 25–29.9
to 40 kg/m2, by year five, the OR
increased to 1.3 and 3.0 in these
same BMI brackets (all p< 0.01).




A weight index was




brackets of< or> 80 kg;





were used and fixed with
gentamicin impregnated
radiopaque PMMA; One
surgeon performed all hip
replacements
Walking ability, defined using the
Charnley scoring system was lower
in patients with a weight index >120
pre-surgery, but similar to patients
with indexes <120 by year 5
(4.9 vs 5.0 points; p=NSig).




56% were women; BMI
brackets were <25,
25–29.9, 30–40 >40 kg/m2





By year 1, stair ascension and
descension difficulty was reported
in 86-88% of very obese patients
compared with 46-55% of
non-obese patients; BMI did not
correlate with change in WOMAC
scores (31.8 and 35.9 points, in
non-obese and very obese
patients, respectively; p> 0.05).
THA = total hip arthroplasty; BMI = body mass index; EUROHIP = European Collaborative Database of Cost and Practice Patterns of Total Hip Replacement.
OR = odds ratio; RR = relative risk; HHS = Harris Hip Score; UCLA = University of California and Los Angeles (UCLA) activity scale; Medical Outcomes SF-12 = Short
Form 12; WOMAC = Western Ontario and McMaster Osteoarthritis Index; VAS = visual analogue scale.
NSig = non-significant.
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function sub-scores than their non-obese counterparts. In
the second study, patients with primary and revision pro-
cedures were administered the WOMAC at five years [28].
of note, the patients with revisions were more often obese
than not. The WOMAC function sub-score was reported
to be lower in obese patients with revision THA compared
with non-obese patients (61.6 vs 70.0 points). This differ-
ence was deemed small but clinically significant.
A sample of Australian patients with primary unilateral
THA was analyzed for differences in WOMAC responses
by year one [34]. The obese patients reported improve-
ments in WOMAC function subscores from 44.6 to 23.3
points while the non-obese patients demonstrated
improvements in this same subscore from 40.7 to 13.7
points. Hence, the non-obese patients showed a greater
relative functional improvement than obese patients at
year one. Stickles et al [35] prospectively assessed
WOMAC responses in persons with THA across the BMI
spectrum: <25, 25–20, 30–35, 35–40 and >40 kg/m2. At
one year after surgery, WOMAC scores were progressively
less with each higher BMI bracket. There were no differ-
ences among BMI brackets in the total complication rate,
medical complication rate or orthopedic complication
rate.Oxford hip scores (OHS)
One study presented responses to the Oxford Hip survey
in groups with low and high BMIs. Andrew et al. [16].
compared the OHS in non-obese, obese and morbidly
obese patients pre-surgery, three months and annually
until year five. By year three, the average OHS was high-
est in the non-obese group and lowest in the morbidly
obese group (19.6 ± 8.6 vs 23.5 ± 11.4 points); this pattern
was maintained out to year five. However, the five year
change in absolute OHS was not different based on BMI,
indicating comparable responsiveness to the procedure
over the long term. There were no differences in the
rates of perisurgical medical complications or long term
femoral stem position, femoral osteolysis or implant
survival.
UCLA activity score
A prospective study that compared the osteolysis rates
and patient satisfaction after THA was conducted by
Lubbeke et al [31]. The patient activity level was assessed
using the UCLA survey at the pre-surgery time point
and at years five and ten after THA. Patients were strati-
fied into non-obese, overweight, and obese groups based
on BMI. While the mean UCLA scores were similar be-
tween groups at follow-up, the 6.8% of obese patients
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overweight and 14.4% of normal weight groups. This
finding was corroborated with lower follow-up HHS in
the obese group compared to the remaining groups.
Obese patients had poorer pain scores and an odds ratio
of 1.44 of developing femoral osteolysis whereas the nor-
mal weight had an odds ratio of 2.64 compared to the
reference overweight group.
Functional tests
Several studies assessed functional capacity with walking
tests, stair climbing, and timed functional tests. In an
early study, walking ability was a primary functional five
year endpoint for a Danish cohort of patients with THA
[20]. Radiographic and surgical outcomes were measured
in addition to walking ability. The Charnley criteria [36]
were applied to walking ability (6 points =walking, no
limp; 5 points = extensive walking, with or without cane,
with limp; 4 points =moderate walking with one crutch
or cane; 3 points = restricted walking with crutches; 2
points =wheelchair transfer activity; 1 point = bedridden)
before and after THA. Patients were stratified based on a
weight index (< or >120% of normal weight for height
and sex) or by body weight (<80 kg or >80 kg). Pre-op-
eratively, walking ability scores were different based on
% of normal weight (1.8 vs 2.3 points in heavy versus
non-heavy patients, respectively; p< 0.05) but not abso-
lute body weight (2.2 points for both groups). Five years
post-THA, Charnely walking scores were not different
based on either expression of body size. While surgical
blood loss was greater in heavy patients compared with
non-heavy patients, there were no significant differences
in operation time, medical complications or loosening of
the implant based on weight.
Naylor et al [34] in Australia, performed short functional
tests in obese and non-obese patients before and at various
time points out to year one. These tests included a 15-
meter walking test and a timed-up-and-go (TUG) test
where an individual rises from a chair and returns to the
chair. While obesity did not preclude improvement in 15
meter walking speed, the trajectory of change was lower in
the obese group by year one, and final walking speeds were
1.37 m/s and 1.14 m/s in non-obese and obese patients, re-
spectively. Similarly, improvements in TUG test time were
slower in the obese group by year one (final TUG times
were 9.2 sec and 12.4 sec in the non-obese and obese
patients). The approximate 30% an 42% improvements in
walk and TUG times were not different based on obesity
status. There was a 2.8% greater chance that obese patients
would use a walking aid at follow-up compared to non-
obese counterparts.
Difficulty ascending and descending stairs was one end-
point in a prospective study of American patients hip or
knee arthroplasty [35]. Among the patients with THA, andit was shown that the percentage of patients in each pro-
gressively higher BMI bracket (<25 to >40 kg/m [2])
reported difficulty with descending and ascending stairs.
This functional pattern was corroborated with self-report
WOMAC data, which showed lower scores in the one year
total WOMAC score and related physical component sub-
score in severely obese patients compared to non-obese
patients. Total medical complication rate was not different
across the BMI spectrum. However, a major limitation to
the study was that the specific technique used to capture
this stair climbing information was not presented in the
methods.
In a cohort of American patients with revision THA, ac-
tivity limitation and dependence on walking aids was
assessed by Singh et al [12] at years two and five post-
THA. The evidence revealed that the odds ratio of devel-
oping moderate-severe physical activity limitation
increased from 1.2 to 2.7 in overweight and morbidly obese
patients. Severe obesity increased the two and five year
odds ratios of developing complete dependence on walking
aids to 2.0 and 2.7 compared with the reference of normal
weight.
Busato et al [3] collected a series of functional measure-
ments in a cohort of Swiss patients with THA at periodic
follow-ups, including walking distance without support,
hip flexion range, stair climbing and putting on shoes and
socks. Data were reported as the percent of patients who
were able to achieve walking >60 minutes, hip flexion
range >90 and capacity for normal stair climb and don-
ning of footwear. Irrespective of time point, fewer obese
patients were able to walk >60 minutes without support
and this percentage continued to lowered 27.2% from year
three to year 12 compared with the 18.5% fewer non-obese
patients. This same pattern occurred with stair climbing
and with tying shoes by year 12. Interestingly, the obese
patients increased the hip flexion range of motion by 7.8%,
whereas the non-obese group lost 11.6% of hip flexion mo-
tion by year 12. In all three BMI strata, pain relief was
achieved in the majority of patients and was largely main-
tained by year 12.
Hip range of motion was assessed in non-obese and
obese patients with cementless THA at a median follow-
up time of 5.1 years in addition to pain ratings, survey
scores and implant survival. Despite equivalent implant
survival rates between groups, obese patients achieved
9.4 less range of movement about the hip than non-
obese patients with flexion, 2 less adduction and 2.8 less
of internal rotation. Interestingly, pain relief and patient
satisfaction with the procedure were similar between
groups at follow-up.
Overview of the findings
Of the evidence included in this review, the surgical
component, cementation or surgical approach did not
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tional outcomes in the obese patient. Of the 23 studies,
16 reported that obesity was associated with lower hip
function survey scores at follow-up, whereas four studies
did not. Five studies revealed negative long term effects
of obesity on various tasks of physical function, and one
study noted no adverse influence of obesity on walking
ability. While obesity does not necessarily preclude func-
tional improvements after surgery, the functional gains
achieved and the self-reported functional ability generally
are lower than those attained by non-obese patients.
Thus, evidence indicates that there is significant pain re-
lief and patient satisfaction after THA in obese patients,
whereas these patients fall short of achieving the same
long term functional level as their non-obese counter-
parts. Hence, in a time frame of as short as one year after
THA, obese patients are already at a functional deficit
compared to non-obese counterparts.
Potential explanations for functional outcomes in the obese
patient
Some postulated mechanisms underlying this finding in-
clude fear of movement and fear avoidance of physical
activities, poor skeletal muscle quality, elevated perceived
effort with physical tasks, and maintenance of pre-surgi-
cal physical activity patterns. Our research laboratory has
recently shown that obese patients fear pain induced by
physical activity and movement, and this corresponds to
lower self-reported physical abilities with tasks related to
mobility (e.g., walking, stair climbing, body transfers and
recreational activities that involve running, start and stop
motions and jumping) [37,38]. Despite a paucity of lit-
erature addressing the interactions of pain, obesity and
joint function over the long term, obese patients can
achieve high satisfaction and pain relief and still not in-
crease participation in physical activities at home and in
the community. Whether this is due to residual fear of
movement and avoidance of activities that may trigger
pain is unknown.
Muscle strength rather than muscle mass may be a
more clinically relevant determinant of functional status
in the older population [39]. Adipose tissue itself contri-
butes to muscle loss through chronic, low grade produc-
tion of inflammatory cytokines, adipokines and free fatty
acids [40]. These chemicals slowly erode muscle mass in
the older obese adult, unfavorably shifting the ratio of
muscle mass to fat mass. In addition, existing muscles
become infiltrated by fat [41], thereby lowering muscle
quality and functional ability of the muscle tissue. Re-
sidual post-operative strength deficits and fat infiltration
may occur in the hip flexors (15% strength difference
compared to non-repaired hip) out to two years [42];
these deficits may contribute to lower functional ability
with tasks that activate these muscles. Hence, independentfrom the improvements in pain and quality of life after a
total hip replacement, the obese patient may not achieve
the same level of function as non-obese patient in part due
to skeletal muscle quality, especially if the patient does not
change physical activity patterns to activate loading bearing
muscle groups after THA.
The level of perceived difficulty and effort with physical
activity is a critical issue for obese individuals, especially
those with BMI≥ 40 kg/m2. Morbidly obese patients have
poor cardiac, metabolic and ventilatory efficiency and have
lower compensatory hyperventilation with exercise [43]. A
given exercise workload may require a lot of energy to
move heavier limb segments against gravity in the mor-
bidly obese individuals (manifested as lower mechanical ef-
ficiency) [44,45]. Self-reported fatigue is higher with
increasing BMI [46]. Mobility related tasks, such as short
and long distance timed walking tests, stair climb. TUG
tests are consistently more challenging and take longer to
perform with increasing BMI [47]. Musculoskeletal pain
may occur at high intensity activities and may be the limit-
ing factor and not true muscle fatigue [45]. Collectively,
the higher perception of muscular effort and discomfort of
dyspnea may discourage this population from regularly en-
gaging in physical activities.
While quantitative evidence of physical activity patterns
after THA in obese adults is sparse, Donovan et al [48].
reported that patient perceptions of physical activity
improved by one year after surgery. A total of 43% and 9%
of the patients felt that their activity level improved “a lot
more” and “a little more” since prior to joint replacement,
respectively. The majority of the referenced studies, how-
ever, showed that weight gain or maintenance typically
occurs after THA, inferring that physical activity levels
were not dramatically altered from pre-surgical levels. It
has been postulated that with the resolution of hip pain
and decreased need for analgesics, normal appetites and
caloric intake returned and counteracted any potential ef-
fect of increased physical activity in the obese patient [49].
Does weight loss after THA improve long term functional
outcomes?
The assumption that THA would reduce hip pain, and
therefore foster increased physical activity and weight
loss in the obese patient is not presently substantiated by
the limited evidence. In fact, several studies report main-
tenance of current weight [48] or continued weight gain
(ranging from 2.5%-3.6% increase in BMI) one to two
years after THA [49-51]. Data suggest that ≥75% of
patients experience weight gain over three years [15].
This trend occurs in men and women, irrespective of
pre-surgical BMI [50]. However, in one prospective
study, the average weight gain by one year was 2.8 kg,
with the change occurring primarily in women [52]. In
another study, non-obese and obese patients did not lose
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amount of weight after surgery [53]. Post-surgical BMI
values at follow-up were independent of improvement in
mobility using WOMAC score [51] or self-reported
improvements in mobility [54]. We surmise that the ma-
jority of patients undergoing primary THA will increase
their BMI given sufficient follow-up time, irrespective of
the outcome [51]. Further investigation of strategies that
can be used to encourage perioperative weight loss and
slow, safe weight loss after surgery will be important for
functional change and preservation of the joint pros-
thesis lifespan.
Clinical implications
Obese patients with THA are less functional than non-
obese counterparts. If over time the obese patient fails to
modify lifestyle, sarcopenic obesity worsens as a spiral of
deconditioning and functional dependence develops. The
ability to generate muscle strength and power will de-
cline without participation in physical activity. As the
obese patient ages and the negative lifestyle behaviors re-
main, obesity-related comorbidities will worsen. Add-
itional joint pains will develop and the joint implant will
ultimately fail earlier in life. Uncontrolled obesity after
THA will result in costly and complicated surgical revi-
sion procedures. This is a serious issue, because the
number of THA performed earlier in obese patients is
growing rapidly in the U.S. Possible solutions to this
combat this problem include: 1) a strong emphasis on
aggressive rehabilitation after THA that focuses on long
term maintenance of skeletal muscle quality and mass,
and 2) consistent, safe monitored weight loss over the
months following the surgery to facilitate physical func-
tion and longevity of the joint implant.
Limitations to the evidence
There are several limitations that deserve comment.
First, the determination of “physical function” varied
widely across the studies. In this population, there is not
yet a standard test battery performed before and after
surgery. Second, the reviewed studies typically did not
report severity or frequency of other musculoskeletal
pain that might be affected by THA. This issue is im-
portant, as the hip joint lies centrally to the lower body
kinematic chain. Correction of hip pain may improve
gait, posture and ambulation, thereby reducing other
joint symptoms in the spine and knee. We assume that
correction of pain and disability in the hip is the mech-
anism underlying functional improvement, particularly
in obese patients, but we are neglecting to address
whether THA has wider reaching effects on overall joint
mechanics and pain symptoms.
A substantial attrition rate occurred in many studies.
Attrition creates selection bias of the population, and inmany studies it was not clear how missing data were
handled. In some cases, only completers were included
in the analysis. Interpretation of long term results is con-
founded by the likelihood of selection bias. The lack of
emphasis on clinical importance has led to misconcep-
tions and disagreements about the interpretation of the
results of clinical trials and a tendency to equate statis-
tical significance with clinical importance. In some
instances, statistically significant results may not be clin-
ically important and, conversely, statistically insignificant
results do not completely rule out the possibility of clin-
ically important effects [55].Future directions
The National Health and Nutrition Examination Survey
III data show that lower body functional impairment is
becoming more prevalent in obese individuals; among
obese persons, 36.8% reported disability in 1994, whereas
42.2% reported disability and functional impairment in
2004 [56]. Development of a battery of functional tests
of hip flexibility, muscle testing and mobility should be
standard practice for THA research to help predict func-
tional success of the surgery. A comprehensive pain and
fear assessment will help determine how systemic pain
relates to the symptoms and changes in the hip joint.
Prospective biomechanical assessments of lower body
kinematics in the surgical and non-surgical limb would
be very useful in tracking the long term joint motion and
physical capabilities. Psychiatric [57], psychosocial [58]
and behavioral traits [59] or genetic phenotypes [60]
associated with severe obesity should be factors to track
in future outcomes studies. There is a dire need for iden-
tification of specific exercise, psychosocial, pain manage-
ment and nutritional interventions that effectively
enhance gains made in physical function over the long
term. Finally, it would be clinically important to deter-
mine what amount of weight loss maximizes implant
lifespan.Conclusions
THA confers significant pain reduction and improvement
in quality of life irrespective of BMI. While functional im-
provement occurs after THA, available evidence indicates
that obese patients are less likely to attain the same level of
physical function over the long term. Uncontrolled obesity
is related to worsening of comorbidities and excessive
health care costs over the long term. Aggressive and sus-
tainable rehabilitation strategies that include physical exer-
cise, psychosocial components and behavior modification
may be highly useful in maximizing and maintaining
weight loss after THA. Furthermore, this type of rehabili-
tation may also reduce the overall health care burden.
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